07 Mar
2017
16:30 E.S.T.

Five Additional Leading Physicians to Join Cellectis Clinical Advisory Board

Read more

06 Mar
2017
16:30 E.S.T.

Cellectis Reports 4th Quarter and Full Year 2016 Financial Results

Read more

07 Feb
2017
16:30 E.S.T.

Cellectis to Present at the LEERINK Partners 6th Annual Global Healthcare Conference on Thursday, February 16, 2017 at 1:30pm ET in New York

Read more

06 Feb
2017
16:30 E.S.T.

FDA Grants Cellectis IND Approval to Proceed with the Clinical Development of UCART123, the First Gene Edited Off-the-Shelf CAR T-Cell Product Candidate developed in the U.S.

Read more

23 Jan
2017
16:30 E.S.T.

Four Prominent Physicians to Join Cellectis Clinical Advisory Board

Read more

23 Jan
2017
16:30 E.S.T.

Cellectis Studies Safety in New CAR Architecture Controlling CAR T-Cell Functions

Read more

04 Jan
2017
16:30 E.S.T.

Cellectis to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 8:00am PT

Read more

03 Jan
2017
16:30 E.S.T.

Cellectis Submits IND Application for UCART123, an Allogeneic Gene Edited CAR T-Cell Product Candidate, in AML and BPDCN

Read more